EP1429740A4 - Formulation de noyau comprenant de la troglitazone et un biguanide - Google Patents
Formulation de noyau comprenant de la troglitazone et un biguanideInfo
- Publication number
- EP1429740A4 EP1429740A4 EP01952549A EP01952549A EP1429740A4 EP 1429740 A4 EP1429740 A4 EP 1429740A4 EP 01952549 A EP01952549 A EP 01952549A EP 01952549 A EP01952549 A EP 01952549A EP 1429740 A4 EP1429740 A4 EP 1429740A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- troglitazone
- biguanide
- core formulation
- formulation
- core
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/021616 WO2003005993A1 (fr) | 2000-05-01 | 2001-07-10 | Formulation de noyau comprenant de la troglitazone et un biguanide |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1429740A1 EP1429740A1 (fr) | 2004-06-23 |
EP1429740A4 true EP1429740A4 (fr) | 2005-01-26 |
Family
ID=32067644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01952549A Withdrawn EP1429740A4 (fr) | 2001-07-10 | 2001-07-10 | Formulation de noyau comprenant de la troglitazone et un biguanide |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1429740A4 (fr) |
JP (1) | JP2004536842A (fr) |
AU (1) | AU2001273290B2 (fr) |
CA (1) | CA2453782A1 (fr) |
MX (1) | MXPA04000181A (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7785627B2 (en) * | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997041842A1 (fr) * | 1996-05-09 | 1997-11-13 | The Trustees Of The University Of Pennsylvania | Particules creuses contenant du calcium et du phosphate du type mineral et destinees a un tissu osseux___________________________ |
US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
WO2000028989A1 (fr) * | 1998-11-12 | 2000-05-25 | Smithkline Beecham P.L.C. | Composition pharmaceutique a liberation modifiee d'un agent de sensibilisation a l'insuline, et d'un autre agent antidiabetique |
DE19860699A1 (de) * | 1998-12-30 | 2000-07-06 | Hexal Ag | Pharmazeutische Zusammensetzung |
WO2000044681A2 (fr) * | 1999-02-01 | 2000-08-03 | The Curators Of The University Of Missouri | Procede de preparation de coques ou de gels a partir de particules de verre |
WO2001035940A2 (fr) * | 1999-11-16 | 2001-05-25 | Smithkline Beecham P.L.C. | Nouvelle composition et utilisation |
WO2001035941A2 (fr) * | 1999-11-16 | 2001-05-25 | Smithkline Beecham P.L.C. | Nouvelle composition et utilisation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451342B2 (en) * | 2000-05-01 | 2002-09-17 | Aeropharm Technology Incorporated | Core formulation comprised of troglitazone and a biguanide |
-
2001
- 2001-07-10 CA CA002453782A patent/CA2453782A1/fr not_active Abandoned
- 2001-07-10 JP JP2003511800A patent/JP2004536842A/ja active Pending
- 2001-07-10 AU AU2001273290A patent/AU2001273290B2/en not_active Ceased
- 2001-07-10 MX MXPA04000181A patent/MXPA04000181A/es unknown
- 2001-07-10 EP EP01952549A patent/EP1429740A4/fr not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997041842A1 (fr) * | 1996-05-09 | 1997-11-13 | The Trustees Of The University Of Pennsylvania | Particules creuses contenant du calcium et du phosphate du type mineral et destinees a un tissu osseux___________________________ |
US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
WO2000027401A1 (fr) * | 1998-11-09 | 2000-05-18 | Warner-Lambert Company | Combinaisons contre le diabete contenant une sulfonyluree, un glitazone et un biguanide |
WO2000028989A1 (fr) * | 1998-11-12 | 2000-05-25 | Smithkline Beecham P.L.C. | Composition pharmaceutique a liberation modifiee d'un agent de sensibilisation a l'insuline, et d'un autre agent antidiabetique |
DE19860699A1 (de) * | 1998-12-30 | 2000-07-06 | Hexal Ag | Pharmazeutische Zusammensetzung |
WO2000044681A2 (fr) * | 1999-02-01 | 2000-08-03 | The Curators Of The University Of Missouri | Procede de preparation de coques ou de gels a partir de particules de verre |
WO2001035940A2 (fr) * | 1999-11-16 | 2001-05-25 | Smithkline Beecham P.L.C. | Nouvelle composition et utilisation |
WO2001035941A2 (fr) * | 1999-11-16 | 2001-05-25 | Smithkline Beecham P.L.C. | Nouvelle composition et utilisation |
Non-Patent Citations (1)
Title |
---|
See also references of WO03005993A1 * |
Also Published As
Publication number | Publication date |
---|---|
MXPA04000181A (es) | 2004-11-22 |
AU2001273290B2 (en) | 2004-10-07 |
EP1429740A1 (fr) | 2004-06-23 |
CA2453782A1 (fr) | 2003-01-23 |
JP2004536842A (ja) | 2004-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2375299B (en) | Playard and a changing table thereof | |
GB2369270B (en) | Cross-charging in a mobile-telecommunication network | |
IL158437A0 (en) | Absorbent article having a multilayer absorbent core | |
HUP0303955A3 (en) | Herbicidal compositions comprising benzoylcyclohexanediones and safeners and a method for their use | |
GB0316651D0 (en) | A universasl software application | |
EP1455793A4 (fr) | Formulation anti-diabete et procede | |
EP1423399A4 (fr) | Chelateurs d'hydroxypyridonate et d'hydroxypyrimidinone | |
PL370563A1 (en) | Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds | |
AU2001227535A8 (en) | A core formulation | |
AU2001227532A1 (en) | A core formulation | |
AU2002337749A1 (en) | Pioglitazone hydrochloride | |
GB2389324B (en) | A novel catalytic formulation and its preparation | |
TW547114U (en) | A racket | |
EP1429747A4 (fr) | Preparation de noyau comprenant un hydrochlorure de pioglitazone et un biguanide | |
EP1511753A4 (fr) | Antimicrobiens et leurs utilisations | |
EP1429732A4 (fr) | Formulation de noyau | |
GB0005122D0 (en) | A ballscrew | |
GB2365032B (en) | A sectional structure and parts thereof | |
EP1429740A4 (fr) | Formulation de noyau comprenant de la troglitazone et un biguanide | |
AU2001273309A1 (en) | Core formulation comprising troglitazone and a biguanide | |
GB0101992D0 (en) | Pesticidal formulation | |
SG104988A1 (en) | Leadframe and component with a leadframe | |
GB0013400D0 (en) | A formulation | |
IL147063A0 (en) | Pesticidal formulation | |
IL153245A0 (en) | New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040109 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20041210 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 9/50 B Ipc: 7A 61K 31/4439 B Ipc: 7A 61K 31/155 B Ipc: 7A 61K 9/16 A |
|
17Q | First examination report despatched |
Effective date: 20050323 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20050912 |